(Q53320452)
Statements
Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: a multicenter, randomized, placebo-controlled, single-blind, dose escalation study. (English)
1 reference
Abraham E
1 reference
Reinhart K
1 reference
Svoboda P
1 reference
Seibert A
1 reference
Olthoff D
1 reference
Dal Nogare A
1 reference
Postier R
1 reference
Hempelmann G
1 reference
Butler T
1 reference
Martin E
1 reference
Zwingelstein C
1 reference
Percell S
1 reference
Shu V
1 reference
Leighton A
1 reference
Creasey AA
1 reference
1 November 2001
1 reference
29
1 reference
2081-2089
1 reference
11
1 reference
Identifiers
1 reference